First Light Asset Management LLC lifted its holdings in shares of Trupanion Inc (NASDAQ:TRUP) by 0.5% during the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 194,778 shares of the financial services provider’s stock after acquiring an additional 958 shares during the period. First Light Asset Management LLC owned 0.56% of Trupanion worth $7,037,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also modified their holdings of the company. Manchester Capital Management LLC raised its position in shares of Trupanion by 100.9% during the 1st quarter. Manchester Capital Management LLC now owns 1,710 shares of the financial services provider’s stock worth $56,000 after acquiring an additional 859 shares in the last quarter. Aperio Group LLC acquired a new stake in shares of Trupanion during the 2nd quarter worth about $166,000. BNP Paribas Arbitrage SA raised its position in shares of Trupanion by 1,247.2% during the 1st quarter. BNP Paribas Arbitrage SA now owns 5,362 shares of the financial services provider’s stock worth $176,000 after acquiring an additional 4,964 shares in the last quarter. US Bancorp DE increased its position in Trupanion by 6.0% during the second quarter. US Bancorp DE now owns 6,145 shares of the financial services provider’s stock worth $222,000 after buying an additional 350 shares during the period. Finally, Angeles Investment Advisors LLC acquired a new position in Trupanion during the first quarter worth approximately $246,000. 96.34% of the stock is currently owned by institutional investors and hedge funds.
NASDAQ:TRUP opened at $26.86 on Friday. The firm has a market cap of $942.47 million, a P/E ratio of -895.33 and a beta of 1.47. The company has a current ratio of 1.80, a quick ratio of 1.80 and a debt-to-equity ratio of 0.15. The stock’s 50 day simple moving average is $27.02 and its 200-day simple moving average is $31.19. Trupanion Inc has a 12-month low of $22.38 and a 12-month high of $37.39.
In other news, insider Darryl Rawlings sold 4,000 shares of the business’s stock in a transaction that occurred on Tuesday, July 2nd. The stock was sold at an average price of $35.42, for a total value of $141,680.00. Following the transaction, the insider now owns 1,519,120 shares of the company’s stock, valued at $53,807,230.40. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In the last three months, insiders sold 21,200 shares of company stock worth $626,825. Corporate insiders own 13.61% of the company’s stock.
TRUP has been the topic of several research analyst reports. Craig Hallum lowered Trupanion from a “buy” rating to a “hold” rating and set a $29.00 price target on the stock. in a research report on Friday, August 16th. Northland Securities reaffirmed a “buy” rating and set a $40.00 price target on shares of Trupanion in a research report on Wednesday, July 31st. Zacks Investment Research lowered Trupanion from a “hold” rating to a “sell” rating in a research report on Friday, August 2nd. BidaskClub raised Trupanion from a “sell” rating to a “hold” rating in a research report on Thursday, September 12th. Finally, Royal Bank of Canada set a $38.00 price target on Trupanion and gave the stock a “buy” rating in a research report on Wednesday, July 31st. One research analyst has rated the stock with a sell rating, two have issued a hold rating and six have given a buy rating to the company. Trupanion has an average rating of “Buy” and a consensus target price of $37.50.
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, and Puerto Rico. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians through third-party referrals and online member acquisition channels.
Featured Story: Buyback
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.